Pathomorphological parameters of sepsis-associated encephalopathy in deceased septic patients without purulent lesions to the brain
DOI:
https://doi.org/10.14739/mmt.2024.2.305087Keywords:
sepsis-associated encephalopathy, sepsis-associated liver injury, neuropathology, immunohistochemistry, ammonia, Alzheimer type 2 astrocytes, microglia, amyloid bodiesAbstract
Sepsis-associated encephalopathy (SAE) clinically manifests by delirium and decreased consciousness less than 15 points on Glasgow Coma Scale. SAE pathophysiology includes neuroinflammation, ischemic-hypoxic and dysmetabolic mechanisms. Despite the high frequency and the important role in thanatogenesis, pathomorphological criteria of SAE remain to be defined.
The aim of the study was to specify the key pathomorphological parameters of sepsis-associated encephalopathy in deceased septic patients without purulent lesions to the brain by defining the changes of neurogliovascular unit and the level of tissue ammonia.
Material and methods. Using pathohistological, histochemical, and immunohistochemical methods we studied cerebral cortex and white matter, hippocampus, thalamus, and cerebellum of 35 deceased septic patients with SAE in comparison with the control group, which included 30 patients who died from acute cardiovascular failure without CNS pathology.
Results. In SAE, small foci of encephalolysis due to thrombosis of microvessels, ischemic-hypoxic and apoptotic changes in neurons are associated with the following parameters that are reliably (p < 0.05) different from the control group: higher (up to 199.48 %) level of tissue ammonia and increased number (up to 316.07 %) of caspase-3+ apoptotic neurons in the cortex, hippocampus, thalamus, and cerebellum; in all studied brain regions, an increased expression level of astrocytic glial fibrillary acidic protein (up to 192.69 %), glutamine synthetase (up to 134.41 %) and aquaporin-4 (up to 400.8 %); significant (up to 947.01 %) expansion of perivascular and pericellular “edematous” spaces, increased (up to 479.58 %) immunopositive area of extravascular CD68+ microgliocytes and increased (up to 374.43 %) proportion of CD68+ ameboid microgliocytes, increased (up to 3.66 times) number of Alzheimer type 2 astrocytes in cerebral cortex, thalamus, and cerebellum; increased (up to 2 times) number of amyloid bodies in the thalamus and cerebellum.
Conclusions. The obtained data indicate that the delirious state, loss of consciousness and other manifestations of SAE are associated with ischemic-hypoxic and ammonia-induced ischemic and apoptotic changes of the brain neurones; small foci of encephalolysis; adaptive remodeling and dystrophic changes of astrocytes; microglial reactiveness with increased proportion of phagocytic microgliocytes; brain edema and dysfunctional glymphatics.
References
Guarino M, Perna B, Cesaro AE, Maritati M, Spampinato MD, Contini C, et al. 2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department. J Clin Med. 202328;12(9):3188. doi: https://doi.org/10.3390/jcm12093188
Garofalo AM, Lorente-Ros M, Goncalvez G, Carriedo D, Ballén-Barragán A, Villar-Fernández A, et al. Histopathological changes of organ dysfunction in sepsis. Intensive Care Med Exp. 2019;7(Suppl 1):45. doi: https://doi.org/10.1186/s40635-019-0236-3
Lu X, Qin M, Walline JH, Gao Y, Yu S, Ge Z, et al. Clinical phenotypes of sepsis-associated encephalopathy: a retrospective cohort study. Shock. 2023;59(4):583-90. doi: https://doi.org/10.1097/SHK.0000000000002092
Singer BH, Dickson RP, Denstaedt SJ, Newstead MW, Kim K, Falkowski NR, et al. Bacterial Dissemination to the Brain in Sepsis. Am J Respir Crit Care Med. 2018;197(6):747-756. doi: https://doi.org/10.1164/rccm.201708-1559OC
Zhao L, Walline JH, Gao Y, Lu X, Yu S, Ge Z, et al. Prognostic Role of Ammonia in Critical Care Patients Without Known Hepatic Disease. Front Med (Lausanne). 2020;7:589825. doi: https://doi.org/10.3389/fmed.2020.589825
Zhao L, Hou S, Na R, Liu B, Wang Z, Li Y, Xie K. Prognostic role of serum ammonia in patients with sepsis-associated encephalopathy without hepatic failure. Front Public Health. 2023;10:1016931. doi: https://doi.org/10.3389/fpubh.2022.1016931
Woźnica EA, Inglot M, Woźnica RK, Łysenko L. Liver dysfunction in sepsis. Adv Clin Exp Med. 2018;27(4):547-51. doi: https://doi.org/10.17219/acem/68363
Zhao J, He Y, Xu P, Liu J, Ye S, Cao Y. Serum ammonia levels on admission for predicting sepsis patient mortality at D28 in the emergency department: A 2-center retrospective study. Medicine (Baltimore). 2020;99(11):e19477. doi: https://doi.org/10.1097/MD.0000000000019477
Numan Y, Jawaid Y, Hirzallah H, Kusmic D, Megri M, Aqtash O, et al. Ammonia vs. Lactic Acid in Predicting Positivity of Microbial Culture in Sepsis: The ALPS Pilot Study. J Clin Med. 2018;7(8):182. doi: https://doi.org/10.3390/jcm7080182
Shulyatnikova TV, Tumanskiy VO. Immunohistochemical expression of GFAP, GS, AQP4, Alzheimer-2-astrocytosis and brain ammonia levels in deceased septic patients without liver failure and those with sepsis-associated liver injury. Art of Medicine. 2023;2(26):138-45. doi: https://doi.org/10.21802/artm.2023.2.26.138
Gutiérrez-de-Juan V, López de Davalillo S, Fernández-Ramos D, Barbier-Torres L, Zubiete-Franco I, Fernández-Tussy P, et al. A morphological method for ammonia detection in liver. PLoS One. 2017;12(3):e0173914. doi: https://doi.org/10.1371/journal.pone.0173914
Long MT, Coursin DB. Undifferentiated non-hepatic hyperammonemia in the ICU: Diagnosis and management. J Crit Care. 2022;70:154042. doi: https://doi.org/10.1016/j.jcrc.2022.154042
Sakusic A, Sabov M, McCambridge AJ, Rabinstein AA, Singh TD, Mukesh K, et al. Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU. Crit Care Med. 2018;46(9):e897-e903. doi: https://doi.org/10.1097/CCM.0000000000003278
Jaeger V, DeMorrow S, McMillin M. The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy. J Clin Transl Hepatol. 20198;7(4):352-61. doi: https://doi.org/10.14218/JCTH.2019.00025
Agarwal AN, Mais DD. Sensitivity and Specificity of Alzheimer Type II Astrocytes in Hepatic Encephalopathy. Arch Pathol Lab Med. 2019;143(10):1256-8. doi: https://doi.org/10.5858/arpa.2018-0455-OA
Akhoundzadeh K, Shafia S. Association between GFAP-positive astrocytes with clinically important parameters including neurological deficits and/or infarct volume in stroke-induced animals. Brain Res. 202115;1769:147566. doi: https://doi.org/10.1016/j.brainres.2021.147566
Heming N, Mazeraud A, Verdonk F, Bozza FA, Chrétien F, Sharshar T. Neuroanatomy of sepsis-associated encephalopathy. Crit Care. 2017;21(1):65. doi: https://doi.org/10.1186/s13054-017-1643-z
Elsherbini DM, Ghoneim FM, El-Mancy EM, Ebrahim HA, El-Sherbiny M, El-Shafey M, et al. Astrocytes profiling in acute hepatic encephalopathy: Possible enrolling of glial fibrillary acidic protein, tumor necrosis factor-alpha, inwardly rectifying potassium channel (Kir 4.1) and aquaporin-4 in rat cerebral cortex. Front Cell Neurosci. 2022;16:896172. doi: https://doi.org/10.3389/fncel.2022.896172
Sepehrinezhad A, Zarifkar A, Namvar G, Shahbazi A, Williams R. Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema. Metab Brain Dis. 2020;35(4):559-78. doi: https://doi.org/10.1007/s11011-020-00549-8
Filchenko I, Blochet C, Buscemi L, Price M, Badaut J, Hirt L. Caveolin-1 Regulates Perivascular Aquaporin-4 Expression After Cerebral Ischemia. Front Cell Dev Biol. 2020;8:371. doi: https://doi.org/10.3389/fcell.2020.00371
Riba M, Augé E, Campo-Sabariz J, Moral-Anter D, Molina-Porcel L, Ximelis T, et al. Corpora amylacea act as containers that remove waste products from the brain. Proc Natl Acad Sci U S A. 2019;116(51):26038-48. doi: https://doi.org/10.1073/pnas.1913741116
Zemtsova I, Görg B, Keitel V, Bidmon HJ, Schrör K, Häussinger D. Microglia activation in hepatic encephalopathy in rats and humans. Hepatology. 2011;54(1):204-15. doi: https://doi.org/10.1002/hep.24326
